Evidence of clinically significant extravascular stores of factor IX

被引：52

作者：

Feng, D. ^{[1
]}

Stafford, K. A. ^{[2
]}

Broze, G. J. ^{[3
]}

Stafford, D. W. ^{[1
]}

机构：

[1] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA

[2] Univ London Imperial Coll Sci Technol & Med, Imperial Coll Sch Med, London, England

[3] Washington Univ, Sch Med, Div Hematol, St Louis, MO USA

来源：

JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2013年 / 11卷 / 12期

关键词：

RECOMBINANT FACTOR-IX; COAGULATION FACTOR-IX; HEMOPHILIA-B PATIENTS; ENDOTHELIAL-CELLS; FACTOR-VIII; FACTOR-X; BINDING; PLASMA; DOMAIN; PHARMACOKINETICS;

D O I：

10.1111/jth.12421

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2176 / 2178

页数：3

共 19 条

[1] A commentary on the differences in pharmacokinetics between recombinant and plasma-derived factor IX and their implications for dosing [J].

Bjorkman, S. .

HAEMOPHILIA, 2011, 17 (02) :179-184

[2]

Briet E., 1977, THESIS

[3] Identification of the endothelial cell binding site for factor IX [J].

Cheung, WF ;

vandenBorn, J ;

Kuhn, K ;

Kjellen, L ;

Hudson, BG ;

Stafford, DW .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :11068-11073

[4] Implications of coagulation factor VIII and IX pharmacokinetics in the prophylactic treatment of haemophilia [J].

Collins, P. W. ;

Fischer, K. ;

Morfini, M. ;

Blanchette, V. S. ;

Bjorkman, S. .

HAEMOPHILIA, 2011, 17 (01) :2-10

[5] REGULATION OF FACTOR-IXA INVITRO IN HUMAN AND MOUSE PLASMA AND INVIVO IN THE MOUSE - ROLE OF THE ENDOTHELIUM AND THE PLASMA PROTEINASE-INHIBITORS [J].

FUCHS, HE ;

TRAPP, HG ;

GRIFFITH, MJ ;

ROBERTS, HR ;

PIZZO, SV .

JOURNAL OF CLINICAL INVESTIGATION, 1984, 73 (06) :1696-1703

[6] Circulating and binding characteristics of wild-type factor IX and certain Gla domain mutants in vivo [J].

Gui, T ;

Lin, HF ;

Jin, DY ;

Hoffman, M ;

Straight, DL ;

Roberts, HR ;

Stafford, DW .

BLOOD, 2002, 100 (01) :153-158

[7] BINDING OF COAGULATION FACTOR-IX AND FACTOR-X TO THE ENDOTHELIAL CELL-SURFACE [J].

HEIMARK, RL ;

SCHWARTZ, SM .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1983, 111 (02) :723-731

[8] Stable gene transfer and expression of human blood coagulation factor IX after intramuscular injection of recombinant adeno-associated virus [J].

Herzog, RW ;

Hagstrom, JN ;

Kung, SH ;

Tai, SJ ;

Wilson, JM ;

Fisher, KJ ;

High, KA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (11) :5804-5809

[9] Enhanced pharmacokinetic properties of a glycoPEGylated recombinant factor IX: a first human dose trial in patients with hemophilia B [J].

Negrier, Claude ;

Knobe, Karin ;

Tiede, Andreas ;

Giangrande, Paul ;

Moss, Judi .

BLOOD, 2011, 118 (10) :2695-2701

[10] Prolonged half-life and preserved enzymatic properties of factor IX selectively PEGylated on native N-glycans in the activation peptide [J].

Ostergaard, Henrik ;

Bjelke, Jais R. ;

Hansen, Lene ;

Petersen, Lars Christian ;

Pedersen, Anette A. ;

Elm, Torben ;

Moller, Flemming ;

Hermit, Mette B. ;

Holm, Pernille K. ;

Krogh, Thomas N. ;

Petersen, Jorn M. ;

Ezban, Mirella ;

Sorensen, Brit B. ;

Andersen, Mette D. ;

Agerso, Henrik ;

Ahmadian, Haleh ;

Balling, Kristoffer W. ;

Christiansen, Marie Louise S. ;

Knobe, Karin ;

Nichols, Timothy C. ;

Bjorn, Soren E. ;

Tranholm, Mikael .

BLOOD, 2011, 118 (08) :2333-2341

← 1 2 →